Our study demonstrated that tumor secreted galectin‐9 suppressed CD8+ T cell cytotoxicity through suppression of proliferation and induction of the PD‐1+ or PD‐1+/TIM3+ subset. This evidence concerns the gene HAVCR2 and neoplasm.